We are live on
!
Find out more
FC
Forte Capital Portfolio holdings
AUM
$930M
1-Year Est. Return
24.11%
This Fund
S&P 500
This Quarter
Est. Return
+6.75%
1 Year Est. Return
+24.11%
3 Year Est. Return
+98.33%
5 Year Est. Return
+137.98%
10 Year Est. Return
+353.08%
AUM
$884M
AUM Growth
+$55.8M
(+6.7%)
Cap. Flow
+$4.98M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
36.72%
Holding
243
New
12
Increased
77
Reduced
129
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$7.21M |
| 2 |
Celestica
CLS
|
+$5.59M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$5.56M |
| 4 |
Booz Allen Hamilton
BAH
|
+$3.5M |
| 5 |
Insight Enterprises
NSIT
|
+$3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$4.63M |
| 2 |
West Pharmaceutical
WST
|
+$3.82M |
| 3 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$2.12M |
| 4 |
Trade Desk
TTD
|
+$2.05M |
| 5 |
iShares Morningstar Mid-Cap Growth ETF
IMCG
|
+$1.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.81% |
| 2 | Consumer Discretionary | 12.28% |
| 3 | Financials | 9.64% |
| 4 | Healthcare | 9.39% |
| 5 | Communication Services | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
GE Vernova
GEV
$264B
| $231K | 0.03% |
+906
| New | +$174K |
|
227
ASML
ASML
$626B
| $224K | 0.03% |
269
+12
| +5% | +$10.7K |
|
228
Copart
CPRT
$27B
| $222K | 0.03% |
4,240
-228
| -5% | -$11.8K |
|
229
Northrop Grumman
NOC
$77.1B
| $216K | 0.02% |
+409
| New | +$200K |
|
230
Analog Devices
ADI
$179B
| $214K | 0.02% |
929
-433
| -32% | -$97.6K |
|
231
Littelfuse
LFUS
$11.2B
| $212K | 0.02% |
800
| – | – |
|
232
Phillips 66
PSX
$84.9B
| $211K | 0.02% |
1,606
-2
| -0.1% | -$270 |
|
233
PayPal
PYPL
$48.9B
| $209K | 0.02% |
+2,675
| New | +$179K |
|
234
Novartis
NVS
$297B
| $205K | 0.02% |
1,778
-202
| -10% | -$22.9K |
|
235
3M
MMM
$90.9B
| $203K | 0.02% |
+1,481
| New | +$181K |
|
236
Amphenol
APH
$198B
| – | – |
-3,671
| Closed | -$247K |
|
237
Pacer US Cash Cows 100 ETF
COWZ
$18.8B
| – | – |
-4,933
| Closed | -$269K |
|
238
First Trust Technology AlphaDEX Fund
FXL
$2.53B
| – | – |
-2,021
| Closed | -$275K |
|
239
Idexx Laboratories
IDXX
$44.1B
| – | – |
-980
| Closed | -$477K |
|
240
Micron Technology
MU
$930B
| – | – |
-1,939
| Closed | -$255K |
|
241
Starbucks
SBUX
$120B
| – | – |
-6,236
| Closed | -$485K |
|
|
SCHW
242
Charles Schwab
SCHW
$183B
| – | – |
-3,478
| Closed | -$256K |
|
Similar funds
PP
SC
CCM
BWA
SAF
NRD
CCP
ECM
Forte Capital's Q3 2024 Portfolio in Review
As of Q3 2024, Forte Capital held 243 positions worth $884M, up 6.7% from $828M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Forte Capital's Q3 2024 filing shows 12 new, 77 increased, 129 reduced and 7 closed positions. Its largest new stake was Insight Enterprises: 14,583 shares worth $3.14M. The largest sale was Nike, an estimated $4.63M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- Forte Capital's largest Q3 2024 buy was Insight Enterprises: 14,583 shares worth $3.14M.
- Forte Capital added most to Novo Nordisk in Q3 2024, an estimated $7.21M increase.
- Forte Capital's biggest Q3 2024 reduction was Nike, cutting an estimated $4.63M.
- Forte Capital fully exited Starbucks in Q3 2024, selling an estimated $485K.
- Forte Capital's ten largest holdings make up 37% of its $884M portfolio in Q3 2024.
- Forte Capital opened 12 new positions and closed 7 in Q3 2024.
- Forte Capital's portfolio value rose 6.7% quarter-over-quarter to $884M.
Based on Forte Capital's 13F filing for Q3 2024, filed 31 Oct 2024.